These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22318390)

  • 1. Natural gene therapy may occur in all patients with generalized non-Herlitz junctional epidermolysis bullosa with COL17A1 mutations.
    Pasmooij AM; Nijenhuis M; Brander R; Jonkman MF
    J Invest Dermatol; 2012 May; 132(5):1374-83. PubMed ID: 22318390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the COL17A1 in non-Herlitz junctional epidermolysis bullosa and amelogenesis imperfecta.
    Nakamura H; Sawamura D; Goto M; Nakamura H; Kida M; Ariga T; Sakiyama Y; Tomizawa K; Mitsui H; Tamaki K; Shimizu H
    Int J Mol Med; 2006 Aug; 18(2):333-7. PubMed ID: 16820943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localized and generalized forms of blistering in junctional epidermolysis bullosa due to COL17A1 mutations in the Netherlands.
    Pasmooij AM; Pas HH; Jansen GH; Lemmink HH; Jonkman MF
    Br J Dermatol; 2007 May; 156(5):861-70. PubMed ID: 17263807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type XVII collagen gene mutations in junctional epidermolysis bullosa and prospects for gene therapy.
    Bauer JW; Lanschuetzer C
    Clin Exp Dermatol; 2003 Jan; 28(1):53-60. PubMed ID: 12558632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral steroid improves bullous pemphigoid-like clinical manifestations in non-Herlitz junctional epidermolysis bullosa with COL17A1 mutation.
    Mabuchi E; Umegaki N; Murota H; Nakamura T; Tamai K; Katayama I
    Br J Dermatol; 2007 Sep; 157(3):596-8. PubMed ID: 17596158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A "late-but-fitter revertant cell" explains the high frequency of revertant mosaicism in epidermolysis bullosa.
    van den Akker PC; Pasmooij AMG; Joenje H; Hofstra RMW; Te Meerman GJ; Jonkman MF
    PLoS One; 2018; 13(2):e0192994. PubMed ID: 29470523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a Novel COL17A1 Compound Heterozygous Mutation in a Chinese Girl with Non-Herlitz Junctional Epidermolysis Bullosa.
    Yao YY; Zhang Y; Xie XH; Chen L; Zhu F; Zhou M
    Curr Med Sci; 2020 Aug; 40(4):795-800. PubMed ID: 32862392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revertant mosaicism in junctional epidermolysis bullosa due to multiple correcting second-site mutations in LAMB3.
    Pasmooij AM; Pas HH; Bolling MC; Jonkman MF
    J Clin Invest; 2007 May; 117(5):1240-8. PubMed ID: 17476356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple correcting COL17A1 mutations in patients with revertant mosaicism of epidermolysis bullosa.
    Pasmooij AM; Pas HH; Deviaene FC; Nijenhuis M; Jonkman MF
    Am J Hum Genet; 2005 Nov; 77(5):727-40. PubMed ID: 16252234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autosomal dominant junctional epidermolysis bullosa.
    Almaani N; Liu L; Dopping-Hepenstal PJ; Lovell PA; Lai-Cheong JE; Graham RM; Mellerio JE; McGrath JA
    Br J Dermatol; 2009 May; 160(5):1094-7. PubMed ID: 19120338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revertant mosaicism: partial correction of a germ-line mutation in COL17A1 by a frame-restoring mutation.
    Darling TN; Yee C; Bauer JW; Hintner H; Yancey KB
    J Clin Invest; 1999 May; 103(10):1371-7. PubMed ID: 10330419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of phenotypic variability in junctional epidermolysis bullosa.
    Kiritsi D; Kern JS; Schumann H; Kohlhase J; Has C; Bruckner-Tuderman L
    J Med Genet; 2011 Jul; 48(7):450-7. PubMed ID: 21357940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced pluripotent stem cells from human revertant keratinocytes for the treatment of epidermolysis bullosa.
    Umegaki-Arao N; Pasmooij AM; Itoh M; Cerise JE; Guo Z; Levy B; Gostyński A; Rothman LR; Jonkman MF; Christiano AM
    Sci Transl Med; 2014 Nov; 6(264):264ra164. PubMed ID: 25429057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Truncated typeXVII collagen expression in a patient with non-herlitz junctional epidermolysis bullosa caused by a homozygous splice-site mutation.
    van Leusden MR; Pas HH; Gedde-Dahl T; Sonnenberg A; Jonkman MF
    Lab Invest; 2001 Jun; 81(6):887-94. PubMed ID: 11406649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paired nicking-mediated COL17A1 reframing for junctional epidermolysis bullosa.
    Bischof J; March OP; Liemberger B; Haas SA; Hainzl S; Petković I; Leb-Reichl V; Illmer J; Korotchenko E; Klausegger A; Hoog A; Binder HM; Garcia M; Duarte B; Strunk D; Larcher F; Reichelt J; Guttmann-Gruber C; Wally V; Hofbauer JP; Bauer JW; Cathomen T; Kocher T; Koller U
    Mol Ther; 2022 Aug; 30(8):2680-2692. PubMed ID: 35490295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pigmentation and melanocyte supply to the epidermis depend on type XVII collagen.
    Gostyński A; Pasmooij AM; Del Rio M; Diercks GF; Pas HH; Jonkman MF
    Exp Dermatol; 2014 Feb; 23(2):130-2. PubMed ID: 24330315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collagen XVII.
    Has C; Kern JS
    Dermatol Clin; 2010 Jan; 28(1):61-6. PubMed ID: 19945617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Junctional epidermolysis bullosa of late onset explained by mutations in COL17A1.
    Yuen WY; Pas HH; Sinke RJ; Jonkman MF
    Br J Dermatol; 2011 Jun; 164(6):1280-4. PubMed ID: 21466533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Features of epidermolysis bullosa simplex due to mutations in the ectodomain of type XVII collagen.
    Pasmooij AM; van der Steege G; Pas HH; Smitt JH; Nijenhuis AM; Zuiderveen J; Jonkman MF
    Br J Dermatol; 2004 Sep; 151(3):669-74. PubMed ID: 15377356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amelioration of junctional epidermolysis bullosa due to exon skipping.
    Kowalewski C; Bremer J; Gostynski A; Wertheim-Tysarowska K; Wozniak K; Bal J; Jonkman MF; Pasmooij AM
    Br J Dermatol; 2016 Jun; 174(6):1375-1379. PubMed ID: 26708078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.